Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2022 16:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directors

Global biopharmaceutical industry senior executive with over 15 years of operational leadership with transactional and capital markets experience spanning both private and public large pharma and...
September 23, 2020 15:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ GS: SBPH) regarding possible breaches...
September 02, 2020 20:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers

WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BMC Stock Holdings, Inc. (NASDAQ GS: BMCH) regarding possible breaches of...
September 22, 2016 07:30 ET | Source: Proteostasis Therapeutics, Inc

Proteostasis Therapeutics Announces Scientific Presentations on New Data at 30th Annual North American Cystic Fibrosis Conference

CAMBRIDGE, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
September 14, 2016 16:03 ET | Source: Proteostasis Therapeutics, Inc

Proteostasis Therapeutics Announces Closing of Follow-On Public Offering of Common Stock

CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused...
September 09, 2016 07:30 ET | Source: Proteostasis Therapeutics, Inc

Proteostasis Therapeutics Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...
August 11, 2016 07:45 ET | Source: Proteostasis Therapeutics, Inc

Proteostasis Therapeutics Issues Mid-Year Corporate Update on Cystic Fibrosis Pipeline Programs

CAMBRIDGE, Mass., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by...